This document discusses the key stages in processing and packaging sterile products, including:
1) Processing, cleaning equipment, sterilization, compounding products, filtration, filling, sealing, and packaging.
2) The main processing stages include cleaning equipment thoroughly, sterilizing using methods like autoclaving, carefully compounding products, filtering solutions, precisely filling containers, sealing containers to maintain sterility, and final packaging.
3) Filling equipment is designed to precisely fill liquids and solids while maintaining sterility, and may include gravity fillers, pressure pump fillers, and vacuum fillers. Containers are sealed using methods like melting glass for ampoules or inserting rubber stoppers for vials.
The document discusses the validation of liquid oral dosage forms. It defines validation as providing a high degree of assurance that a specific manufacturing process will consistently produce a product meeting predetermined specifications. The validation of liquids includes qualifying equipment and facilities. Critical process parameters for manufacturing oral solutions, suspensions, and emulsions include mixing speed and time, homogenization speed and time, and filtration. Acceptance criteria include product clarity, viscosity, pH, assay, sedimentation volume, resuspension, and particle size. At least three successful validation batches are typically required to validate a new product or process.
Scale-up of high area filters for microfiltration of biological fluids - Poin...MilliporeSigma
Scale-up of high area filters for biological fluid microfiltration requires accounting for multiple factors to ensure reliable scaling. Key factors include variability in membrane and device properties, process conditions, and non-membrane pressure losses. High area filters have increased productivity but scaling is more complex. Proper device design and narrowing the performance range of small-scale devices improves scaling accuracy. Accounting for pleat density, height, and support permeability is important. High area filters scale linearly for plugging streams but non-linearly for streams where surface caking occurs. A scaling tool with identical pleat structure confirms expected performance.
This document discusses HVAC systems and cleanroom classification. It explains that HVAC systems are critical for maintaining appropriate environmental conditions to prevent contamination and cross-contamination in cleanrooms. HVAC systems can be designed as single-use or recirculating systems. The document outlines the basic components of HVAC systems and cleanroom classification standards. It emphasizes the importance of HVAC system design, personnel behavior, and regular performance checks to ensure cleanrooms meet classification specifications.
A short presentation on containments which is used for potent drug manufacturing facilities and labs also these are used in biotechnology industries.
Very useful for BSL facility and Oncology/Hormones/Esteroids manufacturing and research.
Single use technology: a regulatory perspectiveTGA Australia
An overview of the regulation of single use technology including Good Manufacturing Practice requirements and the types of deficiencies and issues observed at inspections
The document discusses key aspects of cleaning validation including:
1. Cleaning validation is defined as the process of removing contaminants from equipment and monitoring equipment cleanliness for subsequent manufacturing.
2. The purpose of cleaning validation is to ensure product integrity, prevent cross contamination, and allow for equipment reuse in compliance with regulations.
3. Critical parameters that impact cleaning include cleaning agents, methods, times, temperatures, and establishing worst case scenarios for validation.
Microbiological Environmental Monitoring in Pharmaceutical Facilitydelli_intralab
Merupakan jurnal tentang microbiological environment monitoring in pharma facility
Untuk informasi lebih lanjut atau diskusi mengenai environment monitoring, silahkan hubungi delli.intralab@gmail.com
This document discusses the key stages in processing and packaging sterile products, including:
1) Processing, cleaning equipment, sterilization, compounding products, filtration, filling, sealing, and packaging.
2) The main processing stages include cleaning equipment thoroughly, sterilizing using methods like autoclaving, carefully compounding products, filtering solutions, precisely filling containers, sealing containers to maintain sterility, and final packaging.
3) Filling equipment is designed to precisely fill liquids and solids while maintaining sterility, and may include gravity fillers, pressure pump fillers, and vacuum fillers. Containers are sealed using methods like melting glass for ampoules or inserting rubber stoppers for vials.
The document discusses the validation of liquid oral dosage forms. It defines validation as providing a high degree of assurance that a specific manufacturing process will consistently produce a product meeting predetermined specifications. The validation of liquids includes qualifying equipment and facilities. Critical process parameters for manufacturing oral solutions, suspensions, and emulsions include mixing speed and time, homogenization speed and time, and filtration. Acceptance criteria include product clarity, viscosity, pH, assay, sedimentation volume, resuspension, and particle size. At least three successful validation batches are typically required to validate a new product or process.
Scale-up of high area filters for microfiltration of biological fluids - Poin...MilliporeSigma
Scale-up of high area filters for biological fluid microfiltration requires accounting for multiple factors to ensure reliable scaling. Key factors include variability in membrane and device properties, process conditions, and non-membrane pressure losses. High area filters have increased productivity but scaling is more complex. Proper device design and narrowing the performance range of small-scale devices improves scaling accuracy. Accounting for pleat density, height, and support permeability is important. High area filters scale linearly for plugging streams but non-linearly for streams where surface caking occurs. A scaling tool with identical pleat structure confirms expected performance.
This document discusses HVAC systems and cleanroom classification. It explains that HVAC systems are critical for maintaining appropriate environmental conditions to prevent contamination and cross-contamination in cleanrooms. HVAC systems can be designed as single-use or recirculating systems. The document outlines the basic components of HVAC systems and cleanroom classification standards. It emphasizes the importance of HVAC system design, personnel behavior, and regular performance checks to ensure cleanrooms meet classification specifications.
A short presentation on containments which is used for potent drug manufacturing facilities and labs also these are used in biotechnology industries.
Very useful for BSL facility and Oncology/Hormones/Esteroids manufacturing and research.
Single use technology: a regulatory perspectiveTGA Australia
An overview of the regulation of single use technology including Good Manufacturing Practice requirements and the types of deficiencies and issues observed at inspections
The document discusses key aspects of cleaning validation including:
1. Cleaning validation is defined as the process of removing contaminants from equipment and monitoring equipment cleanliness for subsequent manufacturing.
2. The purpose of cleaning validation is to ensure product integrity, prevent cross contamination, and allow for equipment reuse in compliance with regulations.
3. Critical parameters that impact cleaning include cleaning agents, methods, times, temperatures, and establishing worst case scenarios for validation.
Microbiological Environmental Monitoring in Pharmaceutical Facilitydelli_intralab
Merupakan jurnal tentang microbiological environment monitoring in pharma facility
Untuk informasi lebih lanjut atau diskusi mengenai environment monitoring, silahkan hubungi delli.intralab@gmail.com
This document discusses environmental viable airborne particle testing as part of an environmental sampling program for compounding areas. It outlines that sampling should occur at minimum every 6 months in all compounding areas and include sampling locations, collection methods, frequency, air volume, time of day, and action levels. Active air sampling using a volumetric impaction sampler is called for, collecting a volume of 400mL to 1L. The growth media (TSA and malt extract agar) is incubated and colony forming units per cubic meter are counted and action levels determined. Areas exceeding action levels should be remediated and resampled.
The document discusses design requirements for aseptic manufacturing facilities. Key points include:
- Facility design must facilitate appropriate space, operations, material and waste flows to prevent contamination.
- Critical areas require stringent controls for airborne particles, air changes, airflow velocity, and surface cleanliness.
- Utilities like WFI, steam, and HVAC systems must be designed to stringent quality standards to prevent contamination.
- Documentation and validation are required to prove the facility is built as designed and certified for use.
This presentation provides information on minimizing contamination from human personnel in cleanrooms. It discusses how human skin naturally hosts many microorganisms and how cleanroom garments and practices aim to contain these microbes. Proper gowning techniques and high-quality, tightly woven fabrics are important to limit contamination from the billions of skin cells shed daily and prevent microbes from reaching sensitive products. Understanding the human microbiome helps improve strategies to exclude microorganisms from all body areas.
User Requirement For Moisture Analyser.Pdf.nenalandim
This document outlines the user requirements for a new moisture analyzer model BVC. It will be used in quality control labs to determine moisture content of samples. The analyzer must meet 19 user requirements related to functionality, design, and documentation. Key requirements include utilizing halogen heating, weighing and displaying results in grams, drying samples from 30 seconds to 480 minutes, and complying with ISO quality standards. The analyzer will ensure accurate moisture testing in support of quality control.
This document discusses key considerations for the aseptic manufacturing of sterile pharmaceutical products. It covers classification of clean areas, environmental monitoring, preparation and filtration of solutions, personnel requirements, equipment sterilization, and validation of aseptic processes. The main objectives are to prevent microbial contamination and maintain sterility throughout manufacturing.
This document discusses the validation of sterilization processes for sterile medicines. It defines sterility as a probability of less than 1 in 1 million of a container being contaminated. Sterilization methods discussed include moist heat, dry heat, ethylene oxide gas, radiation, and filtration. Validation of a sterilization process involves developing a protocol, calibrating instruments, developing sterilization cycles, and determining the necessary Fo value to achieve the required sterility assurance level based on the bioburden and most resistant organisms. Moist heat sterilization at 121°C for 15 minutes is provided as an example, which would achieve an Fo value of 15.
Clean Room - A compendium according to approved guidelines.Md Mosaruf Hossan
The document provides an overview of cleanroom classifications according to ISO, US Federal Standard 209E, and European standards. It discusses particle sources and control methods like filtration, dilution with higher air changes, and isolation. PIC/S guidelines recommend grade A environments with precise air control for high-risk aseptic operations, and grade B-D cleanrooms for less critical stages. Microbial limits and air monitoring frequencies are specified depending on the cleanroom grade.
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)MilliporeSigma
This document summarizes a presentation given at a conference on aseptic processing. It discusses challenges implementing pre-use integrity testing (PUPSIT) of sterile filters for final product filtration and provides case studies of both successful and unsuccessful filtration setups. The presentation addresses common issues like filter sizing, complex product formulations that impact integrity testing, and assembly details. It promotes the ability to achieve PUPSIT with current single-use technology and filtration setup options.
Environmental Characterization of Controlled Roomsangelsalaman
This document discusses cleanroom standards and regulations. It defines cleanrooms and zones according to ISO classifications and FDA guidelines. ISO 5 is the highest classification for "critical" areas where products are exposed. ISO 7-8 areas have less stringent controls. Pressure differences between zones are discussed to prevent air flow from contaminating areas. Isolator technology and blow-fill-seal equipment are also summarized. Design of cleanroom suites must exclude external contamination and control cross-contamination between products and zones.
An understanding on requirements to produce Hazardous Pharmaceutical Products. The concept of containment facility and practices are described in easy to understand fashion.
Ophthalmic products are sterile preparations meant for application to or administration into the eye. Common types include eye drops, lotions, ointments, and suspensions. They must meet certain requirements regarding particles, viscosity, tonicity, pH, and sterility. Formulations contain drugs, preservatives, and other excipients. Biologics include antigens that induce antibody responses and antibodies that recognize invading organisms. Major immunoglobulin classes are IgA, IgD, IgE, IgG, and IgM. Immunity can be natural or acquired through active or passive means.
Aseptic Process Sampling to address Risk of Contamination & Containment in co...MilliporeSigma
Watch this webinar here: bit.ly/asepticwebinar2020
In this webinar, you will learn:
- The challenges tied to contamination control within a biopharmaceutical environment.
- What closed processing is, and how sampling solutions are an integral component towards that end.
- Advantages of sterile sampling from both a technical and economical viewpoint; with the review of a technical study confirming contamination risk reduction and total cost of ownership.
- Recommendations and requirements stated by these major regulatory authorities around the monitoring of the manufacturing process with the execution of sampling.
Detailed description:
Biopharmaceutical manufacturers are required to ensure drug product quality attributes for patient safety. Strong contamination control strategies should be considered early in process design, and have direct influence on the production environment and equipment selection.
Sampling at each step is a critical component in maintaining a contamination control strategy. Regulators are critical in the sampling process, as it predicts the state of the product or process, and needs to be Representative. A case study will be presented that demonstrates a closed, robust sampling solution capable of maintaining a sterile flow path when challenged with Brevundimonas diminuta. The sampling option you select can help support your goal in achieving a closed process, improving your risk mitigation strategy and product safety.
This document discusses sterile filtration for pharmaceutical, biotechnology, food and beverage, and medical industries. It describes the major markets for sterile filtration and explains how sterile filters work to remove bacteria and viruses through mechanical retention down to sizes of 0.2-0.3 microns. The document defines key terms like beta ratio, nominal vs. absolute retention rates, and log reduction value (LRV). A sterile filter is considered absolute if it has a beta ratio above 5000 and achieves an LRV of at least 7 per square centimeter, removing 99.99999% of 0.2-0.3 micron particles.
USP 797/800 Cleanroom Compliance by Terra UniversalTerra Universal
Understand the scope and compliance costs of the most recent CGMP standards and USP
guidelines for cleanroom design and operation! Webinar topics covered by our industry-expert speakers include DQSA compliance, designing for USP 800 hazardous drug compounding, and cleanroom cost estimating. Industry experts Will summarize the revised regulations and what theymean for pharmacy cleanrooms. Registrants Will receive Terra Universal's white paper "Designing your compounding Cleanroom for USP/cGMP Compliance."
Speakers
Dr. Chris Munoz, PharmD and Principle Consultant at ITL Consulting
and teaches pharmacy compounding at the University of Southern California (USC)
School of Pharmacy, and serves on the California Pharmacists Association's Policy Committee and Board of Directors. Following Chris's earlier work in compounding pharmacies and for pharmaceutical companies, he began a consulting firm specializing in the business of, and regulatory affairs for, pharmacy compounding.
Dr. Jesse Martinez, PharmD, FASCP and Vice Dean of the College of Pharmacy,
Western University of Heath Sciences
Dr. Jesse Martinez has 37 years Of experience in compounding, sterile and non-sterile pharmacy operations and administration, and research. He has served on local, state and national pharmacy associations and currently teaches fourth-year pharmacy students in advanced Classes that include pharmacist-in-charge training. Jesse consults for the pharmacy industry and is a recognized expert in USP 795, 797 and 300 compliance.
For More Information Please visit
http://www.terrauniversal.com/public/webinar-information-and-downloads.php
http://www.terrauniversal.com/cleanrooms/modular-clean-rooms-x.php
Cleaning Validation in Pharmaceutical Manufacturing - A Regulatory Perspectiv...Obaid Ali / Roohi B. Obaid
This document discusses cleaning validation in pharmaceutical manufacturing from a regulatory perspective. It provides guidance on developing cleaning procedures, validation protocols, sampling methods, analytical methods, and establishing acceptance criteria. It emphasizes that cleaning procedures and validation studies must be thoroughly documented and specific. The validation approach should consider factors like equipment design, products manufactured, and difficulty of cleaning. Deviations and out-of-specification results must be properly investigated. The goal of cleaning validation is to prove cleaning procedures adequately remove residues to predetermined acceptable levels.
Contamination control in pharmaceutical industryclientscomp
Contamination control is important in the pharmaceutical industry to ensure safety and efficacy. Contaminants can make medicines toxic or transmit pathogens. Strict sterilization and containment methods are used, including laminar airflow hoods, sealed hatches, and disposable systems. Decontamination is the first step, using autoclaving, dry heat, or hydrogen peroxide vapor sterilization. Cleanrooms provide isolated ventilation to limit contamination of chemicals, biologicals, and pharmaceutical products from the environment.
This document discusses environmental microbial monitoring (EMM) in cleanrooms and pharmaceutical facilities. It provides an overview of EMM purposes and regulations, who performs EMM, what areas are monitored, sampling plans and methods used. Key points covered include:
- EMM determines microbial and particulate levels to ensure cleanroom quality and identify contamination sources.
- Quality Control and Assurance departments perform EMM to demonstrate safety and ensure GMP compliance.
- Non-viable air, viable air and surface samples are monitored from areas like personnel, equipment and facilities.
- Sampling frequency, sites and methods like air samplers, settle plates, contact plates and swabbing are discussed in accordance with regulations like USP 39
This document discusses cleaning validation which is important to prevent contamination that could affect product safety and quality. It outlines the purpose, importance and levels of cleaning validation. Key aspects covered include developing a master validation plan, defining appropriate cleaning procedures and sampling methods, establishing acceptance criteria, and using validated analytical methods. The conclusion emphasizes that cleaning procedures must be validated to ensure they are reliable and reproducible.
The document provides guidelines on good manufacturing practices for heating, ventilation and air conditioning (HVAC) systems for non-sterile oral solid dosage facilities. It discusses various aspects of HVAC system design including product protection, personnel protection, and environmental protection. Some key points include:
- HVAC systems should be designed to prevent contamination and cross-contamination through control of air filtration levels, air flows, pressures differentials between rooms and other methods.
- Areas are classified based on levels of protection from Level 1 to Level 3. Level 3 areas require the strictest controls on environmental conditions.
- Uni-directional air flows and positive or negative pressure cascades between areas help control contamination risks.
HVAC systems are an integral part of environmental control and include air handling units. AHU are large metal boxes that condition and circulate air, containing components like blowers, filters, and controls for temperature and humidity. Proper filtration is important for pharmaceutical facilities, utilizing filters like HEPA that can remove 99.97% of particles over 0.3 microns through mechanisms like impingement, diffusion, and interception. Dust collectors are also used to control air pollution and maintain clean environments through various collection methods. Regular inspection and maintenance of air handling systems is crucial to ensure quality pharmaceutical production.
This document discusses environmental viable airborne particle testing as part of an environmental sampling program for compounding areas. It outlines that sampling should occur at minimum every 6 months in all compounding areas and include sampling locations, collection methods, frequency, air volume, time of day, and action levels. Active air sampling using a volumetric impaction sampler is called for, collecting a volume of 400mL to 1L. The growth media (TSA and malt extract agar) is incubated and colony forming units per cubic meter are counted and action levels determined. Areas exceeding action levels should be remediated and resampled.
The document discusses design requirements for aseptic manufacturing facilities. Key points include:
- Facility design must facilitate appropriate space, operations, material and waste flows to prevent contamination.
- Critical areas require stringent controls for airborne particles, air changes, airflow velocity, and surface cleanliness.
- Utilities like WFI, steam, and HVAC systems must be designed to stringent quality standards to prevent contamination.
- Documentation and validation are required to prove the facility is built as designed and certified for use.
This presentation provides information on minimizing contamination from human personnel in cleanrooms. It discusses how human skin naturally hosts many microorganisms and how cleanroom garments and practices aim to contain these microbes. Proper gowning techniques and high-quality, tightly woven fabrics are important to limit contamination from the billions of skin cells shed daily and prevent microbes from reaching sensitive products. Understanding the human microbiome helps improve strategies to exclude microorganisms from all body areas.
User Requirement For Moisture Analyser.Pdf.nenalandim
This document outlines the user requirements for a new moisture analyzer model BVC. It will be used in quality control labs to determine moisture content of samples. The analyzer must meet 19 user requirements related to functionality, design, and documentation. Key requirements include utilizing halogen heating, weighing and displaying results in grams, drying samples from 30 seconds to 480 minutes, and complying with ISO quality standards. The analyzer will ensure accurate moisture testing in support of quality control.
This document discusses key considerations for the aseptic manufacturing of sterile pharmaceutical products. It covers classification of clean areas, environmental monitoring, preparation and filtration of solutions, personnel requirements, equipment sterilization, and validation of aseptic processes. The main objectives are to prevent microbial contamination and maintain sterility throughout manufacturing.
This document discusses the validation of sterilization processes for sterile medicines. It defines sterility as a probability of less than 1 in 1 million of a container being contaminated. Sterilization methods discussed include moist heat, dry heat, ethylene oxide gas, radiation, and filtration. Validation of a sterilization process involves developing a protocol, calibrating instruments, developing sterilization cycles, and determining the necessary Fo value to achieve the required sterility assurance level based on the bioburden and most resistant organisms. Moist heat sterilization at 121°C for 15 minutes is provided as an example, which would achieve an Fo value of 15.
Clean Room - A compendium according to approved guidelines.Md Mosaruf Hossan
The document provides an overview of cleanroom classifications according to ISO, US Federal Standard 209E, and European standards. It discusses particle sources and control methods like filtration, dilution with higher air changes, and isolation. PIC/S guidelines recommend grade A environments with precise air control for high-risk aseptic operations, and grade B-D cleanrooms for less critical stages. Microbial limits and air monitoring frequencies are specified depending on the cleanroom grade.
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)MilliporeSigma
This document summarizes a presentation given at a conference on aseptic processing. It discusses challenges implementing pre-use integrity testing (PUPSIT) of sterile filters for final product filtration and provides case studies of both successful and unsuccessful filtration setups. The presentation addresses common issues like filter sizing, complex product formulations that impact integrity testing, and assembly details. It promotes the ability to achieve PUPSIT with current single-use technology and filtration setup options.
Environmental Characterization of Controlled Roomsangelsalaman
This document discusses cleanroom standards and regulations. It defines cleanrooms and zones according to ISO classifications and FDA guidelines. ISO 5 is the highest classification for "critical" areas where products are exposed. ISO 7-8 areas have less stringent controls. Pressure differences between zones are discussed to prevent air flow from contaminating areas. Isolator technology and blow-fill-seal equipment are also summarized. Design of cleanroom suites must exclude external contamination and control cross-contamination between products and zones.
An understanding on requirements to produce Hazardous Pharmaceutical Products. The concept of containment facility and practices are described in easy to understand fashion.
Ophthalmic products are sterile preparations meant for application to or administration into the eye. Common types include eye drops, lotions, ointments, and suspensions. They must meet certain requirements regarding particles, viscosity, tonicity, pH, and sterility. Formulations contain drugs, preservatives, and other excipients. Biologics include antigens that induce antibody responses and antibodies that recognize invading organisms. Major immunoglobulin classes are IgA, IgD, IgE, IgG, and IgM. Immunity can be natural or acquired through active or passive means.
Aseptic Process Sampling to address Risk of Contamination & Containment in co...MilliporeSigma
Watch this webinar here: bit.ly/asepticwebinar2020
In this webinar, you will learn:
- The challenges tied to contamination control within a biopharmaceutical environment.
- What closed processing is, and how sampling solutions are an integral component towards that end.
- Advantages of sterile sampling from both a technical and economical viewpoint; with the review of a technical study confirming contamination risk reduction and total cost of ownership.
- Recommendations and requirements stated by these major regulatory authorities around the monitoring of the manufacturing process with the execution of sampling.
Detailed description:
Biopharmaceutical manufacturers are required to ensure drug product quality attributes for patient safety. Strong contamination control strategies should be considered early in process design, and have direct influence on the production environment and equipment selection.
Sampling at each step is a critical component in maintaining a contamination control strategy. Regulators are critical in the sampling process, as it predicts the state of the product or process, and needs to be Representative. A case study will be presented that demonstrates a closed, robust sampling solution capable of maintaining a sterile flow path when challenged with Brevundimonas diminuta. The sampling option you select can help support your goal in achieving a closed process, improving your risk mitigation strategy and product safety.
This document discusses sterile filtration for pharmaceutical, biotechnology, food and beverage, and medical industries. It describes the major markets for sterile filtration and explains how sterile filters work to remove bacteria and viruses through mechanical retention down to sizes of 0.2-0.3 microns. The document defines key terms like beta ratio, nominal vs. absolute retention rates, and log reduction value (LRV). A sterile filter is considered absolute if it has a beta ratio above 5000 and achieves an LRV of at least 7 per square centimeter, removing 99.99999% of 0.2-0.3 micron particles.
USP 797/800 Cleanroom Compliance by Terra UniversalTerra Universal
Understand the scope and compliance costs of the most recent CGMP standards and USP
guidelines for cleanroom design and operation! Webinar topics covered by our industry-expert speakers include DQSA compliance, designing for USP 800 hazardous drug compounding, and cleanroom cost estimating. Industry experts Will summarize the revised regulations and what theymean for pharmacy cleanrooms. Registrants Will receive Terra Universal's white paper "Designing your compounding Cleanroom for USP/cGMP Compliance."
Speakers
Dr. Chris Munoz, PharmD and Principle Consultant at ITL Consulting
and teaches pharmacy compounding at the University of Southern California (USC)
School of Pharmacy, and serves on the California Pharmacists Association's Policy Committee and Board of Directors. Following Chris's earlier work in compounding pharmacies and for pharmaceutical companies, he began a consulting firm specializing in the business of, and regulatory affairs for, pharmacy compounding.
Dr. Jesse Martinez, PharmD, FASCP and Vice Dean of the College of Pharmacy,
Western University of Heath Sciences
Dr. Jesse Martinez has 37 years Of experience in compounding, sterile and non-sterile pharmacy operations and administration, and research. He has served on local, state and national pharmacy associations and currently teaches fourth-year pharmacy students in advanced Classes that include pharmacist-in-charge training. Jesse consults for the pharmacy industry and is a recognized expert in USP 795, 797 and 300 compliance.
For More Information Please visit
http://www.terrauniversal.com/public/webinar-information-and-downloads.php
http://www.terrauniversal.com/cleanrooms/modular-clean-rooms-x.php
Cleaning Validation in Pharmaceutical Manufacturing - A Regulatory Perspectiv...Obaid Ali / Roohi B. Obaid
This document discusses cleaning validation in pharmaceutical manufacturing from a regulatory perspective. It provides guidance on developing cleaning procedures, validation protocols, sampling methods, analytical methods, and establishing acceptance criteria. It emphasizes that cleaning procedures and validation studies must be thoroughly documented and specific. The validation approach should consider factors like equipment design, products manufactured, and difficulty of cleaning. Deviations and out-of-specification results must be properly investigated. The goal of cleaning validation is to prove cleaning procedures adequately remove residues to predetermined acceptable levels.
Contamination control in pharmaceutical industryclientscomp
Contamination control is important in the pharmaceutical industry to ensure safety and efficacy. Contaminants can make medicines toxic or transmit pathogens. Strict sterilization and containment methods are used, including laminar airflow hoods, sealed hatches, and disposable systems. Decontamination is the first step, using autoclaving, dry heat, or hydrogen peroxide vapor sterilization. Cleanrooms provide isolated ventilation to limit contamination of chemicals, biologicals, and pharmaceutical products from the environment.
This document discusses environmental microbial monitoring (EMM) in cleanrooms and pharmaceutical facilities. It provides an overview of EMM purposes and regulations, who performs EMM, what areas are monitored, sampling plans and methods used. Key points covered include:
- EMM determines microbial and particulate levels to ensure cleanroom quality and identify contamination sources.
- Quality Control and Assurance departments perform EMM to demonstrate safety and ensure GMP compliance.
- Non-viable air, viable air and surface samples are monitored from areas like personnel, equipment and facilities.
- Sampling frequency, sites and methods like air samplers, settle plates, contact plates and swabbing are discussed in accordance with regulations like USP 39
This document discusses cleaning validation which is important to prevent contamination that could affect product safety and quality. It outlines the purpose, importance and levels of cleaning validation. Key aspects covered include developing a master validation plan, defining appropriate cleaning procedures and sampling methods, establishing acceptance criteria, and using validated analytical methods. The conclusion emphasizes that cleaning procedures must be validated to ensure they are reliable and reproducible.
The document provides guidelines on good manufacturing practices for heating, ventilation and air conditioning (HVAC) systems for non-sterile oral solid dosage facilities. It discusses various aspects of HVAC system design including product protection, personnel protection, and environmental protection. Some key points include:
- HVAC systems should be designed to prevent contamination and cross-contamination through control of air filtration levels, air flows, pressures differentials between rooms and other methods.
- Areas are classified based on levels of protection from Level 1 to Level 3. Level 3 areas require the strictest controls on environmental conditions.
- Uni-directional air flows and positive or negative pressure cascades between areas help control contamination risks.
HVAC systems are an integral part of environmental control and include air handling units. AHU are large metal boxes that condition and circulate air, containing components like blowers, filters, and controls for temperature and humidity. Proper filtration is important for pharmaceutical facilities, utilizing filters like HEPA that can remove 99.97% of particles over 0.3 microns through mechanisms like impingement, diffusion, and interception. Dust collectors are also used to control air pollution and maintain clean environments through various collection methods. Regular inspection and maintenance of air handling systems is crucial to ensure quality pharmaceutical production.
HVAC systems are an integral part of environmental control and include air handling units, filters, and controls for temperature and humidity. Air handling units are large metal boxes that condition and circulate air using components like blowers, coils, and filter racks. Proper filtration is important for pharmaceutical facilities to produce dust-free environments using filter types like HEPA that can remove 99.97% of particles over 0.3 microns. Inspection and maintenance of air handling systems and their documentation is critical because they play a major role in pharmaceutical quality.
This document discusses air handling systems used in pharmaceutical facilities. It covers the components of HVAC systems including air handling units, filters, and dust collectors. It describes the mechanisms of filtration including impingement, diffusion, and interception. Common filter types are discussed such as HEPA, packed towers, and membrane filters. Dust collection methods like wet collectors, fabric collectors, and cyclones are also summarized. Proper inspection and maintenance of air handling systems is important to ensure air quality for pharmaceutical manufacturing.
FRS-G FY-YA1000D vs FY-GA1600D comparison chartKenJiang11
The document provides a comparative analysis of the FY-YA1000D and FY-GA1600D plasma air sterilizer products. Key details include:
1. The FY-YA1000D is a mobile air disinfection machine with a corona ring plasma module, while the FY-GA1600D is a cabinet-type machine with a line type plasma module.
2. Both machines have high bacteria removal rates of over 99.9% and low noise levels under 50dB. The FY-GA1600D has a higher CADR and larger coverage area.
3. The control panels of both machines have multi-stage fan speeds, air quality displays, and filters/module replacement reminders
This document provides an overview of HVAC system design for cleanroom facilities. It discusses the importance of indoor air quality in cleanrooms and outlines four fundamental rules for maintaining cleanroom environments. The document then describes key aspects of cleanroom HVAC system design, including filtration requirements, airflow patterns, temperature and humidity control, and monitoring systems. Maintaining proper pressurization, air exchange rates, and filtration are crucial for controlling airborne particle levels in cleanrooms.
This document provides an overview of HVAC design for cleanroom facilities. It discusses the importance of indoor air quality in cleanrooms and outlines the four fundamental rules that apply, including preventing contamination introduction, equipment generation of contaminants, accumulation of contaminants, and elimination of existing contaminants. The document then describes key elements of cleanroom design like architecture, HVAC systems, interaction technology, and monitoring systems. It also discusses filtration systems used in cleanrooms like HEPA and ULPA filters and the principles of filtration like impaction, interception, diffusion, and electrostatic attraction.
Contamination Control in Cleanrooms_Dr.A. AmsavelDr. Amsavel A
Basic’s of Contamination
Sources of Contamination
Environment Specification
Elements of Cleanroom Design and Qualification
Definitions
Control of Contaminations
People, Cleaning, Environment & Material
Operation, Monitoring and Control
Documents and Records
This document discusses air circulation maintenance in sterile and non-sterile pharmaceutical areas. It covers the importance of HVAC systems in maintaining air quality, including components like ducting, filters, and airflow patterns. Different classification systems are used for sterile versus non-sterile areas. HVAC systems can use either full fresh air or air recirculation with HEPA filters. Key parameters to monitor include filter integrity, air changes, pressure, microbial loads, temperature, and humidity. Proper air handling is crucial for pharmaceutical manufacturing to control contamination.
This document discusses heating, ventilation and air conditioning (HVAC) systems and air filtration systems. It describes the basic components of an HVAC system including air handling units, air distribution systems, and air filters. It then focuses on air filtration, discussing the goals of filtration in pharmaceutical facilities. It explains mechanisms of filtration and common types of air filters used, including HEPA and ULPA filters. It also covers dust collection systems and their components and mechanisms.
Source of contamination. Classification of clean rooms. Air flow systems: conventional flow,
unidirectional flow, laminar air flow units. Air filtration mechanisms. Fibrous filters and HEPA
filters. Temperature and humidity control. Building design, construction and use, humidity
control. Personnel, protective clothing, cleaning and disinfection, commissioning tests of clean
and aseptic rooms. Routine monitoring tests. The operation of clean and aseptic rooms. Key
factors in clean room operations.
Source of contamination, Air flow system: conventional, Unidirectional, laminar air flow unit, Air filtration, mechanisms: Fibrous and HEPA filters, Temperature and humidity control, Building design, construction and use, personnel, Protective clothing, cleaning, and disinfecting, commissioning test of clean and aseptic rooms, routine monitoring tests, The operation of clean aseptic room, Key factors in clean room operations.
This document discusses the design and operation of clean rooms. It defines clean rooms and aseptic areas as spaces with controlled particulate and microbial contamination to reduce product contamination. The main sources of contamination are the atmosphere, operators, working surfaces, equipment, and raw materials. Clean rooms are classified based on particle counts, with Class 100 allowing fewer than 100 particles per cubic foot above 0.5 microns. Proper air flow design via conventional, unidirectional laminar, or isolator systems controls contamination. High-efficiency particulate air and ultra-low particulate air filters are used to filter air entering the clean room.
This document provides information about clean rooms and aseptic areas. It defines clean rooms as rooms with controlled particulate and microbial contamination to minimize introduction of contaminants. Aseptic areas are designed to prevent microbial contamination of products during production. Sources of contamination include external sources like the air system as well as internal sources such as operators, equipment and raw materials. Different types of air flows and classifications of clean rooms are described. Key aspects of clean room design include air filtration and personnel protective clothing requirements.
This document provides an overview of GMP manufacturing environments. It discusses how manufacturing environments impact product quality and outlines factors like personnel, equipment, and premises that contribute to quality. The presentation covers cleanroom classifications, levels of protection, sources of contamination, and parameters that define manufacturing environments like air cleanliness, temperature, and pressure. It emphasizes that the environment is critical for preventing contamination and cross-contamination. Cleanroom class depends on the manufacturing process and corresponding levels of protection must be defined based on critical parameters from the air handling system and additional measures.
This document provides an overview of cleanrooms, including their purpose of controlling airborne particle concentrations, classifications based on particle levels, sources of contamination, and design considerations. Cleanrooms aim to maintain cleanliness levels through isolation of contamination sources, filtration of air supplies, and regulating air flow, temperature, and humidity. Particle testing and certification ensure cleanrooms meet standards like ISO 14644-1.
This document provides guidelines for the manufacture of sterile medicinal products in the European Union. It outlines classification grades (A-D) for clean rooms based on airborne particle limits, with Grade A being the highest standard for filling zones. It recommends environmental monitoring for viable and non-viable particles in grades A and B. Guidelines are provided for terminally sterilized products and aseptically prepared products, specifying the appropriate grade for different manufacturing steps. Personnel requirements include training in hygiene and microbiology and limits on those handling non-sterile materials.
This document provides guidelines for the manufacture of sterile medicinal products in the European Union. It outlines classification grades (A-D) for clean rooms based on airborne particle limits, with Grade A being the highest standard for filling zones. It recommends environmental monitoring for viable and non-viable particles in grades A and B. Guidelines are provided for terminally sterilized products and aseptically prepared products, specifying the appropriate grade for different manufacturing steps. Personnel requirements include training in hygiene and microbiology and maintaining high standards of personal cleanliness.
Air sanitation is the system of removing the impurities present in air inside buildings to protect people from infections. Sanitation of air is essential in enclosed places like hospitals and operation rooms.
FREE A4 Cyber Security Awareness Posters-Social Engineering part 3Data Hops
Free A4 downloadable and printable Cyber Security, Social Engineering Safety and security Training Posters . Promote security awareness in the home or workplace. Lock them Out From training providers datahops.com
Digital Marketing Trends in 2024 | Guide for Staying AheadWask
https://www.wask.co/ebooks/digital-marketing-trends-in-2024
Feeling lost in the digital marketing whirlwind of 2024? Technology is changing, consumer habits are evolving, and staying ahead of the curve feels like a never-ending pursuit. This e-book is your compass. Dive into actionable insights to handle the complexities of modern marketing. From hyper-personalization to the power of user-generated content, learn how to build long-term relationships with your audience and unlock the secrets to success in the ever-shifting digital landscape.
The Microsoft 365 Migration Tutorial For Beginner.pptxoperationspcvita
This presentation will help you understand the power of Microsoft 365. However, we have mentioned every productivity app included in Office 365. Additionally, we have suggested the migration situation related to Office 365 and how we can help you.
You can also read: https://www.systoolsgroup.com/updates/office-365-tenant-to-tenant-migration-step-by-step-complete-guide/
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-EfficiencyScyllaDB
Freshworks creates AI-boosted business software that helps employees work more efficiently and effectively. Managing data across multiple RDBMS and NoSQL databases was already a challenge at their current scale. To prepare for 10X growth, they knew it was time to rethink their database strategy. Learn how they architected a solution that would simplify scaling while keeping costs under control.
Connector Corner: Seamlessly power UiPath Apps, GenAI with prebuilt connectorsDianaGray10
Join us to learn how UiPath Apps can directly and easily interact with prebuilt connectors via Integration Service--including Salesforce, ServiceNow, Open GenAI, and more.
The best part is you can achieve this without building a custom workflow! Say goodbye to the hassle of using separate automations to call APIs. By seamlessly integrating within App Studio, you can now easily streamline your workflow, while gaining direct access to our Connector Catalog of popular applications.
We’ll discuss and demo the benefits of UiPath Apps and connectors including:
Creating a compelling user experience for any software, without the limitations of APIs.
Accelerating the app creation process, saving time and effort
Enjoying high-performance CRUD (create, read, update, delete) operations, for
seamless data management.
Speakers:
Russell Alfeche, Technology Leader, RPA at qBotic and UiPath MVP
Charlie Greenberg, host
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/temporal-event-neural-networks-a-more-efficient-alternative-to-the-transformer-a-presentation-from-brainchip/
Chris Jones, Director of Product Management at BrainChip , presents the “Temporal Event Neural Networks: A More Efficient Alternative to the Transformer” tutorial at the May 2024 Embedded Vision Summit.
The expansion of AI services necessitates enhanced computational capabilities on edge devices. Temporal Event Neural Networks (TENNs), developed by BrainChip, represent a novel and highly efficient state-space network. TENNs demonstrate exceptional proficiency in handling multi-dimensional streaming data, facilitating advancements in object detection, action recognition, speech enhancement and language model/sequence generation. Through the utilization of polynomial-based continuous convolutions, TENNs streamline models, expedite training processes and significantly diminish memory requirements, achieving notable reductions of up to 50x in parameters and 5,000x in energy consumption compared to prevailing methodologies like transformers.
Integration with BrainChip’s Akida neuromorphic hardware IP further enhances TENNs’ capabilities, enabling the realization of highly capable, portable and passively cooled edge devices. This presentation delves into the technical innovations underlying TENNs, presents real-world benchmarks, and elucidates how this cutting-edge approach is positioned to revolutionize edge AI across diverse applications.
Programming Foundation Models with DSPy - Meetup SlidesZilliz
Prompting language models is hard, while programming language models is easy. In this talk, I will discuss the state-of-the-art framework DSPy for programming foundation models with its powerful optimizers and runtime constraint system.
Fueling AI with Great Data with Airbyte WebinarZilliz
This talk will focus on how to collect data from a variety of sources, leveraging this data for RAG and other GenAI use cases, and finally charting your course to productionalization.
Monitoring and Managing Anomaly Detection on OpenShift.pdfTosin Akinosho
Monitoring and Managing Anomaly Detection on OpenShift
Overview
Dive into the world of anomaly detection on edge devices with our comprehensive hands-on tutorial. This SlideShare presentation will guide you through the entire process, from data collection and model training to edge deployment and real-time monitoring. Perfect for those looking to implement robust anomaly detection systems on resource-constrained IoT/edge devices.
Key Topics Covered
1. Introduction to Anomaly Detection
- Understand the fundamentals of anomaly detection and its importance in identifying unusual behavior or failures in systems.
2. Understanding Edge (IoT)
- Learn about edge computing and IoT, and how they enable real-time data processing and decision-making at the source.
3. What is ArgoCD?
- Discover ArgoCD, a declarative, GitOps continuous delivery tool for Kubernetes, and its role in deploying applications on edge devices.
4. Deployment Using ArgoCD for Edge Devices
- Step-by-step guide on deploying anomaly detection models on edge devices using ArgoCD.
5. Introduction to Apache Kafka and S3
- Explore Apache Kafka for real-time data streaming and Amazon S3 for scalable storage solutions.
6. Viewing Kafka Messages in the Data Lake
- Learn how to view and analyze Kafka messages stored in a data lake for better insights.
7. What is Prometheus?
- Get to know Prometheus, an open-source monitoring and alerting toolkit, and its application in monitoring edge devices.
8. Monitoring Application Metrics with Prometheus
- Detailed instructions on setting up Prometheus to monitor the performance and health of your anomaly detection system.
9. What is Camel K?
- Introduction to Camel K, a lightweight integration framework built on Apache Camel, designed for Kubernetes.
10. Configuring Camel K Integrations for Data Pipelines
- Learn how to configure Camel K for seamless data pipeline integrations in your anomaly detection workflow.
11. What is a Jupyter Notebook?
- Overview of Jupyter Notebooks, an open-source web application for creating and sharing documents with live code, equations, visualizations, and narrative text.
12. Jupyter Notebooks with Code Examples
- Hands-on examples and code snippets in Jupyter Notebooks to help you implement and test anomaly detection models.
Have you ever been confused by the myriad of choices offered by AWS for hosting a website or an API?
Lambda, Elastic Beanstalk, Lightsail, Amplify, S3 (and more!) can each host websites + APIs. But which one should we choose?
Which one is cheapest? Which one is fastest? Which one will scale to meet our needs?
Join me in this session as we dive into each AWS hosting service to determine which one is best for your scenario and explain why!
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfChart Kalyan
A Mix Chart displays historical data of numbers in a graphical or tabular form. The Kalyan Rajdhani Mix Chart specifically shows the results of a sequence of numbers over different periods.
3. Vulnerable products and treatments
Products or treatments can loose the quality of their
function(s) and/or can harm the user by contamination
These product are found in various industries:
electronics, semiconductors
technical products
(aero)space industry
automotive industry
medical products
pharma, biopharma
healthcare, hospitals
food
cosmetics
4. Contamination mechanisms
The cause of harm is unwanted surface contamination by particles and/or
micro-organisms of critical surfaces during exposure
Important factors are:
The area of the critical surface
The time of exposure
The air cleanliness of the environment
The particle deposition rate during exposure
The surface cleanliness of contact surfaces
The contact area and number of contacts
5. Contamination mechanisms
The air cleanliness determines the particle deposition rate
The particle deposition rate is the deposition of particles larger or equal than the
particle size of interest expressed in number per area (dm2 or m2) per hour.
Particle deposition is driven by sedimentation and air movement (turbulences)
The particle deposition rate is equal to the concentration of particles (N/m3)
times the deposition velocity (m/hr)
6. Contamination control
All measures to limit the particle deposition rate
Limit exposure
Clean controlled environment (cleanroom or clean zone)
Separated space with overpressure (limit introduction of particles)
Controlled transfer into cleanroom via air locks (limit introduction of particles)
Ventilation by filtered air (removal of airborne particles)
• Dilution (non-unidirectional airflow)
• Displacement (unidirectional air flow)
Cleaning (removal of surface particles)
Prevent contact with unclean surfaces (do not contact critical surfaces)
7. Cleanroom
Segregation
Physical
• Box in box (low emitting construction materials)
• Air locks
• Rooms and zones with different air cleanliness levels
By HEPA/ULPA filtered air flow
• Overpressure
• Air flow direction by pressure control
Ventilation (air volume rate, (non-)unidirectional)
Cleaning
All surfaces easy to clean
8. Ventilation concepts
Unidirectional
Vertical
• with raised perforated floor or low wall returns
Horizontal with perforated opposite wall
Air change rate 100 – 600 per hour
Non unidirectional
Vertical from 0.4 to 1.4 m2 terminal filters
• smaller units sometimes used of air diffusers
• raised perforated floor or low wall returns
Air change rate 5 – 100 per hour
9. Separative devices
Separated space that can not be accessed by a person
Open
Ventilation by vertical/horizontal unidirectional airflow (laminar airflow cabinet)
Safety cabinet with exhaust
Closed
Loading by transfer interface
Access by fixed gloves or half suit with gloves
Manipulation by robotic systems
10. Cleanroom operation
Access by personnel Introduction of particles and micro-organisms
Goods transfer Introduction of particles and micro-organisms
Logistics Distribution of particles and micro-organisms
Working methods Introduction and distribution of particles and micro-organisms
Operating equipment Introduction of particles and micro-organisms
Cleaning Removal of particles and micro-organisms
Cleanroom surfaces
Tools and equipment
Product surfaces
12. Product contamination risk
Product contamination risk depends on severity and likelihood of contamination
Product surfaces are contaminated by particle deposition
Particles can carry micro-organisms
Product surface can also be contaminated by contact transfer
Contact surfaces are contaminated by particle deposition
Surface contamination can be removed by cleaning
Product cleaning can damage product surfaces
Product contamination is determined by particle deposition rate or
microbial deposition rate, product area and time of exposure
13. Product contamination risk
Risk Assessment
What can harm the functions of product?
Critical surfaces and critical particle sizes
Location(s) critical surface is exposed
Acceptable final surface cleanliness
Initial surface cleanliness
Acceptable particle contamination during exposure
Contamination mechanisms are particle deposition and
contact transfer from unclean surfaces
14. Product contamination risk
Risk assessment
Risk = probability x severity of consequences
Severity increases with particle size
Probability of particle contamination =
Particle deposition rate PDR x product area x time of exposure
PDR limit determines air cleanliness
15. Microbe carrying particles (MCP’s)
Micro-organisms are mostly carried by particles.
The number of micro-organisms (in colony
forming units) is a fraction m of all particles.
m depends on particle size D and cleanroom class.
Average MCP size: d = 12 µm or D = 20 µm
Most micro-organisms are dispersed by personnel,
therefore in ISO 5 m is higher than in ISO 8, although the total number
of particles and micro-organisms is lower.
MDR = m.PDR
0,0
0,2
0,4
0,6
0,8
1,0
0 20 40 60 80 100 120 140 160 180 200
m
Particlesizeinµm
Estimated of value m,
ratio microbial and particle deposition
ISO 8
ISO 7
ISO 6
ISO 5
16. Particle deposition rate
Particle deposition rate depends on air cleanliness
Particle deposition rate depends on particle size
Air cleanliness depends on operation:
Introduction of particles by sources
• Personnel
• Goods
• Equipment
Distribution of particles
Re-entry of particles
• Reduced by cleaning
Resulting air cleanliness depends on ventilation system
17. Relation between air cleanliness and
particle deposition rate
The supply of cleanroom air determines the air cleanliness by dilution of
the total number particles introduced in the air per time and the ventilation efficiency
𝐶 =
𝑆
ε𝑄
where C is the number of particles per m3
S is number of emission of particles per second
ε is ventilation effciency
Q supply volume rate m3/s
The removal efficiency is related to the air change rate of the supplied air and the
ventilation efficiency: ε.Q/room volume = ε.air change rate = ε.acr
18. Cleanroom qualification
Cleanroom class determines the maximum
concentration of the worst location in the
cleanroom
Room area determines measurement locations
Selected particle size determines limit
concentration and minimum sample volume
State of occupancy
Cleanroom monitoring is the frequent
measurement of the air cleanliness at a critical
location
Recovery rate is determined by the removal
efficiency and thus by: ε.acr
ISO class Particles
≥ 0.5 µm/m3
Particles
≥ 5 µm/m3
9 35,200,000 293,000
8 3,520,000 29,300
7 352,000 2,930
6.5 111,000 953
6 35,200 293
5.5 11,100 (95)
5 3,520 (29)
Most used part of classification table
19. ISO 14644-1 classification table
Table for classification of air clealiness by particle concentration
0,1 µm 0,2 µm 0,3 µm 0,5 µm 1 µm 5 µm
1 10
2 100 24 10
3 1,000 237 102 35
4 10,000 2,370 1,020 352 83
5 100,000 23,700 10,200 3,520 832
6 1,000,000 237,000 102,000 35,200 8,320 293
7 352,000 83,200 2,930
8 3,520,000 832,000 29,300
9 35,200,000 8,320,000 293,000
ISO Class
number (N)
Maximum allowable concentrations (particles/m3
) for particles equal to and
greater than the considered sizes, shown below:
Sample collection limitations for both particles in low concentrations and sizes > 1 um make classification at
this particle size inapprpopriate, due to potetial losses in the sampling system.
Sampling and statistical limitations for particles in low concentrations make classification inappropriate.
20. State of occupancy
As build: empty cleanroom.
At rest: with equipment, no people.
Operational: with people, result depends
on balance between source strength and
supplied clean air.
The concentration of particles ≥ 5 µm is
almost zero “at rest” but high in
“operational”.
21. Removal efficiency by air flow
Airborne particles can be removed by air flow.
Larger particles will deposit on all surfaces.
Deposition velocity depends on Stokes law.
Deposited particles must be removed by cleaning.
In non unidirectional ventilation:
The removal efficiency depends on the particles size and the air change rate;
The air cleanliness depends on the total sources strength and the air supply
volume and removal efficiency.
In unidirectional air flow the removal efficiency depends on the air
velocity and the unidirectionality.
25. Resulting air cleanliness during operation
In operation personnel causes increase of
particle concentration.
Particle size distribution changes from at rest
to operational occupancy state.
26. Air cleanliness
Number of particles per m3 air is function of particle size:
In at rest situation:
the number of particles is determined by the quality of the cleanroom installation
the number of particles is proportional to the square of the particle size (d2)
In operation:
the number of particles is determined by the number of personnel
the local number of particles varies with the location and activity of personnel
the number of particles is proportional to the particle size (d)
The removal efficiency of the cleanroom installation decreases rapidly with particle size (>5µm).
Particles that are not removed deposit on all surfaces.
Surface particle can become airborne under influence of turbulent airflow.
27. Particle deposition rate
PDR determines likelihood of contamination
Direct
Indirect via contact surfaces
PDR depends on:
Contamination sources
Cleanroom installation
Cleaning
28. Monitoring air cleanliness at a critical location
Monitor particle concentration regularly at critical locations during operation
ISO 14644-2:2015
Determine critical locations by risk assessment
Make a monitoring plan
Set measurement time and frequency
Critical locations
Particle sizes of interest
Set action and alert levels
Real time measurement shows the impact of activities by personnel
29. Particle deposition rate PDR
PDR is number of particles per area per hour
Number of particles ≥ D µm per m2 per hour
ISO 14644-17:2020 Particle deposition rate applications
ISO 14644- 3:2019 Measurement methods
31. Relation between particle deposition rate and air
cleanliness for particles between 5 and 50 µm
A cleanroom is used to control and
limit the particle deposition during
operation.
Relation between airborne particles <
5 µm is not very clear since most
particles do not deposit and are
removed by air flow.
For particles ≥ 5 µm (D= d= 5 µm)
Hamberg found a relation between air
cleanliness C5 and particle deposition
rate PDR5:
PDR5 = 81.2* C5
0.773 per m2 per hour
33. Particle deposition monitoring with the APMON
Advanced Particle deposition MONitor
Particle deposition rate can be measured using a witness plates plus microscopic
inspection (time and labour consuming)
Particle deposition can be measured real time using one or more APMON sensors
34.
35. APMON data
The APMON counts every set sampling period the number of
deposited particle, their size and cross section area.
From this data the following information can be derived:
Deposition event screen
Differential and cumulative particle size distribution Screen
Coverage event screen and total area coverage
Particle Deposition Rate, Class or Level
Particle Obscuration Rate
The real-time screens will create operator awareness.
The data in the screen s can be exported in a .csv file
43. Cumulative particle size distribution
< 30 µm: impact of cleanroom installation
30-100 µm: impact of people and logistics:
Number of people
Garments and changing procedures
Discipline and working methods
Transfer of goods
> 100 µm: impact cleaning program:
Cleaning of large surfaces by cleaners
Cleaning of workplaces tools and equipment by operators
Cleaning of incoming goods
44. Important ISO standards
ISO 14644-2:2015 Monitoring to provide evidence of cleanroom performance
related to air cleanliness by particle concentration
ISO 14644-3:2019 Test methods (including Particle deposition test)
ISO 14644-9:2012 Classification of surface cleanliness with respect to particle
concentration
ISO 14644-13:2017 Cleaning of surfaces to achieve defined levels of cleanliness
in terms of particle and chemical classifications
ISO 14644-17:DIS2019 Particle deposition rate applications
EN17141:2019 Biocontamination
45. Particle deposition rate level
PDRL = PDR.D
where PDR is the particle deposition rate of particles ≥ D µm /m2/hr
PDR = C.u
where C is the particle concentration and u is the deposition velocity
PDR = ΔCS / T
where ΔCS = CS – CS initial and T is the time of exposure
46. Product contamination risk
Product are contaminated by deposition
ND = PDRL * A * T / D
where ND is the expected number of particles ≥ D µm
A is the product area
Products can also be contaminated by contact transfer
ND = n * δ * Acontact * CS = n * δ * Acontact * PDR * T
where n is the number of contacts, δ is the transfer efficiency
Acontact is the contact area
ND = PDRL * A * T * (1 + n * δ) / D where D is the critical particle size
47. APMON 100
Travel case
Mini-pc with i5 processor
APMON Sensor (no battery, no Bluetooth)
1 Witness cartridge
USB with User guide
Optional
Extra Witness cartridge(s)
LCD screen mouse and keyboard
Brookhuis ADI Cleanroom 47
48. APMON 200
As APMON 100 +
APMON Sensor (with battery and Bluetooth)
2 battery’s and
battery charger (for 3 battery’s)
Optional
2nd APMON sensor (with travel case, battery and Bluetooth and witness
cartridge)
Extra Witness cartridge(s)
LCD screen mouse and keyboard
Witness cartridge exchange program refurbished (per 4 pieces)
Brookhuis ADI Cleanroom 48
49. APMON PRO
Travel case
Base computer with i7 processor and battery charger (for 3 battery’s)
APMON sensor (with travel case, battery and Bluetooth and witness cartridge)
2 Witness cartridge
2 battery’s
USB with User guide
Optional
Extra Witness cartridge(s)
Extra APMON sensors (with travel case, battery and Bluetooth and witness cartridge)
LCD screen mouse and keyboard
Witness cartridge exchange program refurbished (per 4 pieces)
Brookhuis ADI Cleanroom 49
50. Use of particle deposition data
To set limits based cleanliness requirements
Contamination control solution is a combination of clean zones
(from cleanroom to separate devices)
Operational procedures
Monitor performance of cleanroom installation
Balance between particle sources and ventilation
Monitor performance of operational procedures
Transfer of particles into cleanroom
Generation of particles in the cleanroom
Distribution of particles in the cleanroom
Removal of particles by cleaning
51. Aspects that influence particle deposition rate
Particle deposition rate impacts the product contamination risk.
Particle deposition rate data provides guidance to the improvement of operational quality.
Critical aspects and activities are:
Transfer
Preparation
Cleaning
Behaviour
Awareness of personnel
Garment selection
Entry and exit procedures and working methods